MSLOF yields 3.37% · JNJ yields 2.13%● Live data
📍 MSLOF pulled ahead of the other in Year 1
Combined, MSLOF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MSLOF + JNJ for your $10,000?
Mitsui O.S.K. Lines, Ltd. engages in the marine transportation business in Japan and internationally. The company operates through Dry Bulk Business, Energy Transport Business, Product Transport Business, and Associated Businesses. Its fleet consists of dry bulk carriers for the transportation of iron ore, coal, grain, wood, wood chips, cement, fertilizer, and salt and steel products; crude oil tankers; tankers that transport refined petroleum products, such as gas oils, naphtha, and gasoline; chemical tankers that transport liquid chemical products; methanol carriers; and LPG carriers. The company's fleet also includes car carriers that transport passenger cars and construction machinery; containerships; and ferries and coastal RoRo ships. In addition, it operates container terminals; floating storage and regasification units; and floating production, storage, and offloading systems, as well as offers logistics services, such as air and ocean freight forwarding, trucking, customs clearance, warehousing, inspection, and heavyweight and oversized cargo transport, as well as buyers' consolidation. Further, the company is involved in ocean shipping related businesses comprising tugboat operation, land transport, maritime consulting, travel, office building leasing, property management, finance, trading, insurance, ICT systems, temporary staffing, supporting an oil stockpile project, nautical charts, and other businesses. As of March 31, 2021, it operated 268 dry bulkers; 280 tankers, LNG carriers, and steaming coal carriers; 60 containerships; 1 cruise ship; and 170 product transport vessels, as well as 2 other vessels. The company was founded in 1884 and is headquartered in Tokyo, Japan.
Full MSLOF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.